193 related articles for article (PubMed ID: 23852020)
21. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.
Huang CC; Chen CT; Huang TS; Shinoda H
Eur Arch Otorhinolaryngol; 1996; 253(7):385-9. PubMed ID: 8891480
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
[TBL] [Abstract][Full Text] [Related]
23. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
Liu D; Ma X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
[TBL] [Abstract][Full Text] [Related]
24. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
Shinoda H; Huang CC
Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
[TBL] [Abstract][Full Text] [Related]
25. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.
Yamamoto-Fukuda T; Akiyama N
Curr Opin Otolaryngol Head Neck Surg; 2020 Oct; 28(5):291-295. PubMed ID: 32796271
[TBL] [Abstract][Full Text] [Related]
26. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
27. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
[TBL] [Abstract][Full Text] [Related]
28. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
29. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of psoriatic skin tissue for identification of differentially expressed proteins: up-regulation of GSTP1, SFN and PRDX2 in psoriatic skin.
Ryu J; Park SG; Park BC; Choe M; Lee KS; Cho JW
Int J Mol Med; 2011 Nov; 28(5):785-92. PubMed ID: 21805023
[TBL] [Abstract][Full Text] [Related]
31. Expression of CYLD and NF-kappaB in human cholesteatoma epithelium.
Byun JY; Yune TY; Lee JY; Yeo SG; Park MS
Mediators Inflamm; 2010; 2010():796315. PubMed ID: 20414373
[TBL] [Abstract][Full Text] [Related]
32. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
33. Taurine Supplementation Alleviates Puromycin Aminonucleoside Damage by Modulating Endoplasmic Reticulum Stress and Mitochondrial-Related Apoptosis in Rat Kidney.
Stacchiotti A; Favero G; Lavazza A; Monsalve M; Rodella LF; Rezzani R
Nutrients; 2018 May; 10(6):. PubMed ID: 29843457
[TBL] [Abstract][Full Text] [Related]
34. Endoplasmic reticulum stress-inducible protein GRP94 is associated with an Mg2+-dependent serine kinase activity modulated by Ca2+ and GRP78/BiP.
Ramakrishnan M; Schönthal AH; Lee AS
J Cell Physiol; 1997 Feb; 170(2):115-29. PubMed ID: 9009140
[TBL] [Abstract][Full Text] [Related]
35. Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma.
Chung JH; Lee SH; Park CW; Kim KR; Tae K; Kang SH; Oh YH; Pyo JY
Otolaryngol Head Neck Surg; 2015 Dec; 153(6):1024-30. PubMed ID: 26124267
[TBL] [Abstract][Full Text] [Related]
36. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
Shinoda H; Huang CC
Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory.
Sudhoff H; Tos M
Am J Otol; 2000 Nov; 21(6):786-92. PubMed ID: 11078064
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
Welkoborsky HJ; Jacob RS; Hinni ML
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
[TBL] [Abstract][Full Text] [Related]
39. Expression of beta-defensins in human middle ear cholesteatoma.
Park K; Moon SK; Choung YH; Choi HS
Acta Otolaryngol; 2003 Jan; 123(2):236-40. PubMed ID: 12701748
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of ubiquitinated proteins by proteomics reveals the role of the ubiquitin proteasome system in the regulation of Grp75 and Grp78 chaperone proteins during intestinal inflammation.
Bertrand J; Tennoune N; Marion-Letellier R; Goichon A; Chan P; Mbodji K; Vaudry D; Déchelotte P; Coëffier M
Proteomics; 2013 Nov; 13(22):3284-92. PubMed ID: 24030972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
